Statin Use is Not Associated with Future Long-Term Care Admission: Extended Follow-Up of Two Randomised Controlled Trials

Drugs and Aging

Volumn 35, Issue 7, 2018, Pages 657-663

  Burton, Jennifer K ^a   Papworth, Richard ^b   Haig, Caroline ^b   McCowan, Colin ^b   Ford, Ian ^b   Stott, David J ^b   Quinn, Terence J ^b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; PRAVASTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CLAUDICATION; FEMALE; FOLLOW UP; HEART INFARCTION; HOSPITAL ADMISSION; HUMAN; HYPERTENSION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; OUTCOME ASSESSMENT; PRESCRIPTION; PRIMARY PREVENTION; PRIORITY JOURNAL; SECONDARY HEALTH CARE; SOCIAL ISOLATION; SOCIAL STATUS; SURVIVAL RATE; CONTROLLED STUDY; HOSPITALIZATION; PROPORTIONAL HAZARDS MODEL; RANDOMIZED CONTROLLED TRIAL; SCOTLAND; STATISTICS AND NUMERICAL DATA;

AGED; FEMALE; FOLLOW-UP STUDIES; HOSPITALIZATION; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LONG-TERM CARE; MALE; PRAVASTATIN; PROPORTIONAL HAZARDS MODELS; SCOTLAND;

EID: 85048676033     PISSN: 1170229X     EISSN: 11791969     Source Type: Journal    
DOI: 10.1007/s40266-018-0560-4     Document Type: Article

References (28)

1. Ford I, Murray H, Packard CJ, et al. Long-term follow-up of the West of Scotland Coronary Prevention Study. N Engl J Med. 2007;357(15):1477–86
2. Davies JT, Delfino SF, Feinberg CE, et al. Current and emerging uses of statins in clinical therapeutics: a review. Lipid Insights. 2016;9:13–29
3. McGuinness B, Craig D, Bullock R, Passmore P. Statins for the prevention of dementia. Cochrane Database Syst Rev. 2016;(1):CD003160
4. Scott D, Blizzard L, Fell J, Jones G. Statin therapy, muscle function and falls risk in community-dwelling older adults. QJM. 2009;102(9):625–33
5. Salkeld G, Cameron ID, Cumming RG, et al. Quality of life related to fear of falling and hip fracture in older women: a time trade off study. BMJ. 2000;320:241–6
6. Quinn TJ, McArthur K, Ellis G, Stott DJ. Functional assessment in older people. BMJ. 2011;343:d4681
7. Rubin EB, Buehler AE, Halpern SD. States worse than death among hospitalized patients with serious illnesses. JAMA Intern Med. 2016;176:1557–9
8. Ribbe MW, Ljunggren G, Steel K, et al. Nursing homes in 10 nations: a comparison between countries and settings. Age Ageing. 1997;26(Suppl 2):3–12
9. Shepherd J, Cobbe SM, Ford I, et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med. 1995;333(20):1301–7
10. Shepherd J, Blauw GJ, Murphy MB, et al. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet. 2002;360(9346):1623–30
11. WOSCOPS Study Group. Screening experience and baseline characteristics in the West of Scotland Coronary Prevention Study. Am J Cardiol. 1995;76:485–91
12. Ford I, Blauw GJ, Murphy MB, et al. A prospective study of pravastatin in the elderly at risk (PROSPER) screening experience and baseline characteristics. Curr Control Trials Cardiovasc Med. 2002;3:8
13. Ford I, Murray H, McCowan C, Packard CJ. Long-term safety and efficacy of lowering low-density lipoprotein cholesterol with statin therapy: 20-year follow-up of West of Scotland Coronary Prevention Study. Circulation. 2016;133(11):1073–80
14. The West of Scotland Coronary Prevention Study Group. A coronary primary prevention study of Scottish men aged 45–64 years: trial design. J Clin Epidemiol. 1992;45(8):849–60
15. Shepherd J, Blauw GJ, Murphy MB, et al. The design of a prospective study of pravastatin in the elderly at risk (PROSPER). PROSPER Study Group. PROspective Study of Pravastatin in the Elderly at Risk. Am J Cardiol. 1999;84(10):1192–7
16. Carstairs V, Morris R. Deprivation and health in Scotland. Health Bull (Edinb). 1990;48(4):162–75
17. McLoone P, Boddy FA. Deprivation and mortality in Scotland, 1981 and 1991. BMJ. 1994;309(6967):1465–70
18. Barry SJ, Dinnett E, Kean S, et al. Are routinely collected NHS administrative records suitable for endpoint identification in clinical trials? Evidence from the West of Scotland Coronary Prevention Study. PLoS One. 2013;8(9):e75379
19. Gnjidic D, Le Couteur DG, Blyth FM, et al. Statin use and clinical outcomes in older men: a prospective population-based study. BMJ Open. 2013;3(3):e002333
20. Pruchno R, Hahn S, Wilson-Genderson M. Cigarette smokers, never-smokers, and transitions: implications for successful aging. Int J Aging Hum Dev. 2012;74(3):193–209
21. Harrison JK, Walesby KE, Hamilton L, et al. Predicting discharge to institutional long-term care following acute hospitalisation: a systematic review and meta-analysis. Age Ageing. 2017;46(4):547–58
22. Luppa M, Luck T, Weyerer S, et al. Prediction of institutionalization in the elderly. A systematic review. Age Ageing. 2010;39(1):31–8
23. Doubal FN, Ali M, Batty GD, et al. Big data and data repurposing: using existing data to answer new questions in vascular dementia research. BMC Neurol. 2017;17(1):72
24. Ruscica M, Macchi C, Pavanelo C, Corsini A, Sahebkar A, Sirtoni CR. Appropriateness of statin prescription in the ederly. Eur J Intern Med. 2018;50:33–40
25. Murphy C, Bennett K, Fahey T, et al. Statin use in adults at high risk of cardiovascular disease mortality: cross-sectional analysis of baseline data from The Irish Longitudinal Study on Ageing (TILDA). BMJ Open. 2015;5(7):e008017
26. Lloyd SM, Stott DJ, de Craen AJ, et al. Long-term effects of statin treatment in elderly people: extended follow-up of the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER). PLoS One. 2013;8(9):e72642
27. Sever PS, Chang CL, Gupta AK, et al. The Anglo-Scandinavian Cardiac Outcomes Trial: 11 year mortality follow-up of the lipid lowering arm in the UK. Eur Heart J. 2011;32:2525–32
28. Ridker PM, Lonn E, Paynter NP, Glynn R, Yusuf S. Primary prevention with statin therapy in the elderly. Circulaton. 2017;135:1979–81